Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Redirecting In vivo Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection

Published version of a preprint

Abstract

A hostile tumor microenvironment interferes with the development and function of the adaptive immune response. Here we report the mechanisms by which large numbers of tumor-infiltrating macrophages and dendritic cells (DC) can be redirected to become potent effectors and activators of the innate and adaptive immunity, respectively. We use adenoviral delivery of the CCL16 chemokine to promote accumulation of macrophages and DC at the site of preestablished tumor nodules, combined with the Toll-like receptor 9 ligand CpG and with anti-interleukin-10 receptor antibody. CpG plus anti-interleukin-10 receptor antibody promptly switched infiltrating macrophages infiltrate from M2 to M1 and triggered innate response debulking large tumors within 16 hours. Tumor-infiltrating DC matured and migrated in parallel with the onset of the innate response, allowing the triggering of adaptive immunity before the diffuse hemorrhagic necrosis halted the communication between tumor and draining lymph nodes. Treatment of B6>CXB6 chimeras implanted with BALB/c tumors with the above combination induced an efficient innate response but not CTL-mediated tumor lysis. In these mice, tumor rejection did not exceed 25%, similarly to that observed in CCR7-null mice that have DC unable to prime an adaptive response. The requirement of CD4 help was shown in CD40-KO, as well as in mice depleted of CD4 T cells, during the priming rather than the effector phase. Our data describe the critical requirements for the immunologic rejection of large tumors: a hemorrhagic necrosis initiated by activated M1 macrophages and a concomitant DC migration to draining lymph nodes for subsequent CTL priming and clearing of any tumor remnants.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-4262

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Cited by

See all 549

Metadata

Authors
Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P.
Affiliations
  • Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
  • 2Schering-Plough Laboratory for Immunological Research, Dardilly, France
Venue
Cancer Research
Published
2005-04-15
Volume
65
Issue
8
Pages
3437-3446
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2126767360
Cited by
549
References
45
Citations by year
2026: 4 · 2025: 16 · 2024: 17 · 2023: 28 · 2022: 28 · 2021: 19 · 2020: 30 · 2019: 31 · 2018: 24 · 2017: 36 · 2016: 31 · 2015: 37 · 2014: 44 · 2013: 34 · 2012: 32
FWCI
7.21
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
tumor-infiltrating macrophages, dendritic cells, tumor microenvironment, tumor rejection, adenoviral gene transfer, CpG, TLR9, macrophage polarization, dendritic cell migration, draining lymph nodes, CTL priming, CD4+ T cell help, CD40, CCR7, tumor immunology
MeSH terms
Adenoviridae, Animals, Dendritic Cells, DNA-Binding Proteins, Female, Macrophages, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Mice, Inbred C57BL, Oligonucleotides, Receptors, Cell Surface, Receptors, Interleukin, Mice, Knockout, Interleukin-12, CpG Islands, Chemokines, CC, Toll-Like Receptor 9, Mice, Receptors, Interleukin-10

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Redirecting In vivo Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-4262
The paper
Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005). Redirecting In vivo Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-4262

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.